The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% year-over-year; regulatory submission for prefilled syringe ...
Abstract: The concept of magnetic suspension balance (MSB) represents a novel approach to the noncontact sensing of trace sample mass. Nevertheless, the actual processing and assembly are challenging ...
ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback